Cytokinetics
CYTK
CYTK
181 hedge funds and large institutions have $1.47B invested in Cytokinetics in 2020 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 86 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
8% more capital invested
Capital invested by funds: $1.36B → $1.47B (+$108M)
0.24% more ownership
Funds ownership: 97.37% → 97.6% (+0.24%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Holders
181
Holding in Top 10
7
Calls
$62.7M
Puts
$50.4M
Top Buyers
| 1 | +$71.9M | |
| 2 | +$40.7M | |
| 3 | +$30.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.7M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$22.3M |
Top Sellers
| 1 | -$78.9M | |
| 2 | -$11.8M | |
| 3 | -$7.51M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.44M |
| 5 |
EP
Eversept Partners
New York
|
-$3.34M |